[EN] PENTACYCLIC OXEPINES AND DERIVATIVES THEREOF, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] OXEPINES PENTACYCLIQUES ET LEURS DERIVES, COMPOSITIONS ET METHODES ASSOCIEES
申请人:LILLY CO ELI
公开号:WO2004009578A2
公开(公告)日:2004-01-29
The present invention provides a compound of the formula (I) wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C2-C6 alkyl); R0, R2 and R3 are each independently -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), -OSO2(C2-C6 alkyl) or halo; R4 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, diisopropylamino, or 1-hexamethyleneimino; n is 2 or 3 X is -S- or -HC=CH-; G is -O-, -S-, -SO-, SO2, or -N(R5)-, wherein R5 is -H or C1-C4 alkyl; and Y is -O-, -S-, -NH-, -NMe-, or -CH2-; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions thereof, optionally in combination with estrogen and progestin; methods of inhibiting a disease associated with estrogen deprivation; and methods for inhibiting a disease associated with an aberrant physiological response to endogenous estrogen.
本发明提供了化合物(I)的公式,其中R1为-H,-OH,-O(C1-C4烷基),-OCOC6H5,-OCO(C1-C6烷基)或-OSO2(C2-C6烷基);R0,R2和R3各自独立地为-H,-OH,-O(C1-C4烷基),-OCOC6H5,-OCO(C1-C6烷基),-OSO2(C2-C6烷基)或卤素;R4为1-哌啶基,1-吡咯烷基,甲基-1-吡咯烷基,二甲基-1-吡咯烷基,4-吗啉基,二甲氨基,二乙氨基,二异丙基氨基或1-己亚甲基亚胺基;n为2或3,X为-S-或-HC = CH-;G为-O-,-S-,-SO-,SO2或-N(R5)-,其中R5为-H或C1-C4烷基;Y为-O-,-S-,-NH-,-NMe-或-CH2-;或其药学上可接受的盐;以及与雌激素和孕激素组合的药物组合物;用于抑制与雌激素缺乏有关的疾病的方法;以及用于抑制与内源性雌激素异常生理反应有关的疾病的方法。